Dan Shell, MD
Plastic Surgery · Southaven, MSNPI 1043316821
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,550 of the $2,553 with a category attached, or 60.7%. AbbVie accounts for 61.4% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2021 at $1,582 and has fallen 94.8% since, to $82 in 2025.
Across 30 payments — averaging $85.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Biotissue Holdings Inc.$297
- Aroa Biosurgery Incorporated$211
- Sientra, Inc.$191
- Kerecis Limited$56
- Coopersurgical, Inc.$44
- plus $186 from 8 others
What the payments were for
- Speaking & faculty fees$1,55061%
- Food & beverage$1,00339%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 3 | $1,568 |
| Biotissue Holdings Inc. | 7 | $297 |
| Aroa Biosurgery Incorporated | 3 | $211 |
| Sientra, Inc. | 3 | $191 |
| Kerecis Limited | 3 | $56 |
| Coopersurgical, Inc. | 1 | $44 |
| TELA Bio, Inc. | 3 | $38 |
| Acera Surgical, Inc. | 1 | $32 |
| Motiva USA, LLC | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $24 |
| Heron Therapeutics, Inc. | 1 | $23 |
| Solventum Corporation | 1 | $16 |
| Smith+Nephew | 1 | $14 |
| Mentor Worldwide LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,553 in reported general payments places this provider in the 65th percentile of 25 plastic surgery providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 54 | $290 |
| Minocycline Hcl | 18 | $253 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $235 |
| Ciprofloxacin Hcl | 15 | $233 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 44 | $157 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Southaven
- Marc WalkerJackson$229K
- Fred BlackledgeJackson$16K
- Daniel RichardsonBiloxi$13K
- Ian HoppeJackson$11K
- Derek CulnanJackson$8K
- Laura HumphriesJackson$8K
- Richard PecuniaHattiesburg$7K
- William RenoHattiesburg$4K
- Rudolph RunnelsFlowood$2K
- Daniel ShellOxford$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.